NL7412659A - Werkwijze ter bereiding van thienylfenyl o-(aminoalkyl)-ketonoximen en furylfenyl o-(aminoalkyl)-ketonoximen alsmede farma- ceutische preparaten die deze verbindingen als actieve component bevatten. - Google Patents

Werkwijze ter bereiding van thienylfenyl o-(aminoalkyl)-ketonoximen en furylfenyl o-(aminoalkyl)-ketonoximen alsmede farma- ceutische preparaten die deze verbindingen als actieve component bevatten.

Info

Publication number
NL7412659A
NL7412659A NL7412659A NL7412659A NL7412659A NL 7412659 A NL7412659 A NL 7412659A NL 7412659 A NL7412659 A NL 7412659A NL 7412659 A NL7412659 A NL 7412659A NL 7412659 A NL7412659 A NL 7412659A
Authority
NL
Netherlands
Prior art keywords
ketonoximes
aminoalkyl
furylphenyl
ceutic
thienylphenyl
Prior art date
Application number
NL7412659A
Other languages
English (en)
Original Assignee
Cerpha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerpha filed Critical Cerpha
Publication of NL7412659A publication Critical patent/NL7412659A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/46Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70Nitro radicals
    • C07D307/71Nitro radicals attached in position 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/42Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
    • C07D333/44Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms attached in position 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
NL7412659A 1973-10-19 1974-09-25 Werkwijze ter bereiding van thienylfenyl o-(aminoalkyl)-ketonoximen en furylfenyl o-(aminoalkyl)-ketonoximen alsmede farma- ceutische preparaten die deze verbindingen als actieve component bevatten. NL7412659A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7337444A FR2248033B1 (nl) 1973-10-19 1973-10-19

Publications (1)

Publication Number Publication Date
NL7412659A true NL7412659A (nl) 1975-04-22

Family

ID=9126699

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7412659A NL7412659A (nl) 1973-10-19 1974-09-25 Werkwijze ter bereiding van thienylfenyl o-(aminoalkyl)-ketonoximen en furylfenyl o-(aminoalkyl)-ketonoximen alsmede farma- ceutische preparaten die deze verbindingen als actieve component bevatten.

Country Status (19)

Country Link
US (1) US4029808A (nl)
JP (3) JPS50111064A (nl)
AT (1) AT339890B (nl)
BE (1) BE821237A (nl)
CA (1) CA1064491A (nl)
CH (1) CH601279A5 (nl)
CS (1) CS192537B2 (nl)
DD (1) DD115118A5 (nl)
DE (2) DE2449205C2 (nl)
FR (1) FR2248033B1 (nl)
GB (1) GB1436307A (nl)
HU (1) HU170388B (nl)
IL (1) IL45772A (nl)
NL (1) NL7412659A (nl)
OA (1) OA04796A (nl)
PH (1) PH12992A (nl)
PL (1) PL99875B1 (nl)
YU (1) YU36514B (nl)
ZA (1) ZA746631B (nl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207319A (en) * 1973-10-19 1980-06-10 Albert Rolland S.A. Thienyl or furyl phenyl O-hetero amino alkyl oximes and use thereof
US4148911A (en) * 1977-07-08 1979-04-10 Societe Anonyme Dite Albert Rolland S.A. Method of treating respiratory disorders
FR2428036A1 (fr) * 1978-06-08 1980-01-04 Rolland Sa A Nouveaux intermediaires de synthese pour la preparation de 0-(amino alkyl) oximes diaromatiques
US4246277A (en) * 1979-06-22 1981-01-20 Albert Rolland S.A. Lowering the concentration of plasma triglycerides
FR2480752A1 (fr) * 1980-04-21 1981-10-23 Cherqui Jean Nouveaux composes derives de la phenylthiazolylcetone, leur procede d'obtention et les compositions pharmaceutiques en contenant
JPS56174550U (nl) * 1980-05-27 1981-12-23
DK270488D0 (da) * 1988-05-18 1988-05-18 Novo Industri As Hidtil ukendte o-substituerede ketoximer
EP0754684A4 (en) * 1994-04-01 1998-05-13 Shionogi & Co OXIME DERIVATIVES AND BACTERICIDE CONTAINING IT AS ACTIVE INGREDIENTS
US6268312B1 (en) * 1994-04-01 2001-07-31 Shionogi & Co., Ltd. Oxime derivative and bactericide containing the same as active ingredient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3084171A (en) * 1961-10-19 1963-04-02 Abbott Lab 5-nitro-2-furylamidine and alkyl 5-nitro-2-furylimidate
US3272833A (en) * 1963-10-09 1966-09-13 Abbott Lab Certain substituted 5-nitro-2-furylamidoximes
NL6810133A (nl) * 1968-07-18 1970-01-20
US3895039A (en) * 1972-11-06 1975-07-15 Roussel Uclaf Carbamaldoximes

Also Published As

Publication number Publication date
DD115118A5 (nl) 1975-09-12
IL45772A (en) 1978-04-30
JPS5373556A (en) 1978-06-30
US4029808A (en) 1977-06-14
AT339890B (de) 1977-11-10
ATA829274A (de) 1977-03-15
HU170388B (nl) 1977-06-28
FR2248033B1 (nl) 1977-03-11
PL99875B1 (pl) 1978-08-31
YU277774A (en) 1982-02-25
FR2248033A1 (nl) 1975-05-16
DE2463088C1 (de) 1982-07-15
DE2449205C2 (de) 1982-03-11
OA04796A (fr) 1980-08-31
CA1064491A (en) 1979-10-16
CH601279A5 (nl) 1978-06-30
JPS5325555A (en) 1978-03-09
IL45772A0 (en) 1974-12-31
BE821237A (fr) 1975-02-17
AU7415574A (en) 1976-04-15
GB1436307A (en) 1976-05-19
CS192537B2 (en) 1979-08-31
ZA746631B (en) 1976-02-25
JPS50111064A (en) 1975-09-01
YU36514B (en) 1984-02-29
JPS5538946B2 (nl) 1980-10-07
PH12992A (en) 1979-10-29
DE2449205A1 (de) 1975-04-24

Similar Documents

Publication Publication Date Title
NL7502664A (nl) Werkwijze ter bereiding van antibiotische aculeacinen, alsmede preparaten die deze ver- bindingen als actieve component bevatten.
NL7714329A (nl) Werkwijze ter bereiding van 3-de-0-methylforti- micinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7414186A (nl) Werkwijze ter bereiding van 1-ftalazonderivaten alsmede van farmaceutische preparaten die deze derivaten als actieve componenten omvatten.
NL7705584A (nl) Werkwijze ter bereiding van tertiaire imidazoly- alcoholen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7702548A (nl) Werkwijze ter bereiding van 3,7-digesubstitueerde- -3-cefem-4-carbonzuurverbindingen, alsmede farma- ceutische preparaten die deze verbindingen als actieve component bevatten.
NL7700379A (nl) Werkwijze ter bereiding van anthracyclinegly- cosiden, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7412659A (nl) Werkwijze ter bereiding van thienylfenyl o-(aminoalkyl)-ketonoximen en furylfenyl o-(aminoalkyl)-ketonoximen alsmede farma- ceutische preparaten die deze verbindingen als actieve component bevatten.
NL7604797A (nl) Werkwijze ter bereiding van nieuwe antibacteriele middelen alsmede preparaten die deze verbindingen als actieve component bevatten.
NL7506680A (nl) Werkwijze ter bereiding van (alpha)-amino- of (alpha)-for- myl-(alpha)-(p-acyloxyfenyl)aceetamidocefalosporanzuren, alsmede farmaceutische preparaten die deze ver- bindingen als actieve component bevatten.
NL7607975A (nl) Werkwijze ter bereiding van difenylsulfiden alsmede farmaceutische preparaten die deze verbindingen als actieve component omvatten.
NL7708982A (nl) Werkwijze ter bereiding van dihydro-oxo-nicotine- zuren, alsmede farmaceutische preparaten die de- ze verbinding als actieve component bevatten.
NL7613041A (nl) Werkwijze ter bereiding van picolinezuurderiva- ten alsmede preparaten die deze verbindingen als actieve component omvatten.
NL7409752A (nl) Werkwijze ter bereiding van 1,4-digesubstitueer- de piperidinen alsmede farmaceutische preparaten die deze verbindingen als actieve componenten omvatten.
NL7702180A (nl) Werkwijze ter bereiding van 9-gesubstitueerde- -8-azapurinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7412302A (nl) Werkwijze ter bereiding van pyrazoliumverbindin- gen, alsmede herbicide preparaten die deze ver- bindingen als actieve component bevatten.
NL7613334A (nl) Werkwijze ter bereiding van carbamaat-sulfenyl- -carbamoylfluorideverbindingen, alsmede pestici- de preparaten die deze verbindingen als actieve component omvatten.
NL7515085A (nl) Werkwijze ter bereiding van cefalosporinederiva- ten als antimicrobiele preparaten die deze deri- vaten als actieve componenten bevatten.
NL7602480A (nl) Werkwijze ter bereiding van insecticide prepa- raten.
NL7513011A (nl) Werkwijze ter bereiding van 1,2,3,4-tetrahydroiso- chinolinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7607494A (nl) Werkwijze ter bereiding van 2-benzopyranonderi- vaten alsmede geneeskundige preparaten die deze verbindingen als actieve component bevatten.
NL7606457A (nl) Werkwijze ter bereiding van 7(beta)-acyloxycefalospo- rinen en 7(beta)-hydroxy-tussenprodukten alsmede farma- ceutische preparaten die de eerste verbindingen als actieve component omvatten.
NL7608659A (nl) Werkwijze ter bereiding van styrylamidinen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7504577A (nl) Werkwijze ter bereiding van 6-azido-4,6-preg- nadieno (3,2-c) pyrazolen, alsmede van farma- ceutische preparaten die deze verbindingen als actieve componenten bevatten.
NL7414486A (nl) Werkwijze ter bereiding van cefalosporine derivaten, alsmede antibacteriele preparaten die deze verbindingen als actieve component bevat- ten.
NL7410364A (nl) Werkwijze ter bereiding van antibiotische ver- bindingen en preparaten die deze verbindingen als actieve component bevatten.

Legal Events

Date Code Title Description
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed